Psilocybin mushrooms trigger a cascade of changes in your brain, starting with a chemical conversion in your gut and ending with a temporary rewiring of how brain regions communicate with each other. The active compound binds to serotonin receptors concentrated across your outer brain, dissolving the usual boundaries between neural networks and producing the vivid perceptual shifts, emotional intensity, and sense of ego dissolution that define the psychedelic experience. Some of these changes last well beyond the trip itself.
From Mushroom to Active Compound
Psilocybin itself doesn’t actually do much. It’s a prodrug, meaning your body has to convert it into its active form, psilocin, before anything happens. This conversion starts in your gut and liver, where enzymes strip a phosphate group off the psilocybin molecule. The process is fast, which is why effects typically begin within 20 to 40 minutes of eating dried mushrooms.
Once psilocin enters your bloodstream, it crosses the blood-brain barrier easily. Its molecular shape closely resembles serotonin, one of the brain’s key chemical messengers. That resemblance is what allows psilocin to interact with serotonin receptors, particularly a type called the 5-HT2A receptor. These receptors are densely packed across the neocortex, the wrinkled outer layer of the brain responsible for perception, thought, and sense of self. The evidence is now strong that the 5-HT2A receptor is the critical molecular trigger for the psychedelic experience. Psilocin also binds weakly to a few other serotonin receptor types, but its affinity for the serotonin transporter (the protein that recycles serotonin) is roughly 100 times lower, meaning it works primarily by stimulating receptors rather than flooding synapses with extra serotonin.
Your Brain’s Default Wiring Breaks Down
Your brain normally operates in organized networks, groups of regions that fire together in coordinated patterns. The most studied of these is the default mode network (DMN), which is active when you’re daydreaming, thinking about yourself, or mentally time-traveling into the past or future. It’s sometimes described as the seat of your narrative self, the running inner monologue that stitches your sense of identity together.
Psilocybin reliably decreases connectivity within the DMN. Specifically, it decouples two key hubs: one in the front of the brain (the medial prefrontal cortex) and one toward the back (the posterior cingulate cortex). Blood flow and neural activity in both regions drop. Higher psilocin levels in the blood correlate directly with greater suppression of DMN connectivity. This is significant because the degree of DMN disruption maps closely onto subjective experience. People who score highest on measures of “mystical” or “peak” experiences show the greatest decreases in DMN connectivity. The feeling of ego dissolution, where the boundary between self and world seems to melt, tracks specifically with the decoupling of those front and back DMN hubs.
Networks That Never Talk Start Talking
As the DMN quiets down, something else happens: the walls between separate brain networks start to dissolve. Normally, your brain is modular. Sensory networks, attention networks, and self-referential networks each do their own thing with limited crosstalk. Psilocybin breaks that pattern. Brain imaging shows that psilocybin causes more than threefold greater disruption to functional connectivity than a stimulant comparison drug, driven by widespread desynchronization that reduces the distinctions between networks.
In practical terms, this means regions that don’t ordinarily share information begin exchanging signals. The brain shifts from a segregated, modular structure to a more globally interconnected one. This cross-network communication likely underlies many hallmark features of a trip: synesthesia (seeing sounds or hearing colors), the sense that abstract concepts have physical weight, or the feeling that music is something you can feel moving through your body. It also helps explain the unusual thought patterns people report, where ideas that seem completely unrelated suddenly feel deeply connected.
Psilocybin also increases glutamate signaling and glucose metabolism throughout the brain, suggesting neurons are working harder and communicating more broadly even as their usual organized patterns fall apart. Meanwhile, the power of the brain’s electrical signals broadly decreases, as though the usual dominant rhythms are loosening their grip to let noisier, more diverse patterns emerge.
Your Sensory Filter Gets Disrupted
The thalamus sits deep in the center of your brain and functions as a relay station, filtering and routing sensory information before it reaches your cortex. Under normal conditions, it gates what gets through. You don’t consciously process every photon hitting your retina or every sound wave entering your ear because the thalamus screens out what’s irrelevant.
Psilocybin alters the thalamus’s internal organization, particularly in regions called the mediodorsal and pulvinar nuclei. These areas show decreased connectivity to visual and default mode networks. The effect is nuanced: some thalamic connections to the cortex increase modestly overall, but specific, functionally important pathways decrease sharply. The net result is that your sensory filter becomes less selective. More raw perceptual data floods into conscious awareness, which contributes to the visual intensity, pattern recognition on blank surfaces, and sensory richness people describe during a trip.
Emotional Processing Shifts
The amygdala, your brain’s threat-detection center, responds differently under psilocybin. In healthy volunteers shown images of negative and neutral facial expressions, amygdala reactivity was significantly lower after psilocybin compared to placebo. This dampened fear response correlated directly with increases in positive mood. People weren’t just less reactive to threatening stimuli; the reduction in amygdala activity predicted how much better they felt.
This combination of reduced fear processing and heightened emotional openness may explain why psilocybin experiences often involve confronting difficult memories or emotions without the usual defensive response. It’s also one of the mechanisms being studied in the context of treatment-resistant depression, where the amygdala tends to be hyperactive in response to negative stimuli.
New Connections Grow After the Trip Ends
Perhaps the most striking finding in recent research is that psilocybin triggers physical structural changes in neurons. A study published in Neuron found that a single dose led to roughly 10% increases in both the size and density of dendritic spines in the frontal cortex. Dendritic spines are the tiny protrusions on brain cells where they receive signals from other neurons, so more spines and bigger spines mean more potential for communication between cells.
This remodeling happened fast, within 24 hours of a single dose, and was still present one month later. The spine formation rate roughly doubled in females (from 7% to 15%) and increased significantly in males (from 6% to 10%). Importantly, the rate at which existing spines were eliminated didn’t change, so psilocybin was adding new connections without destroying old ones. About a third of the newly formed spines were still present 34 days after administration, suggesting lasting structural change. The mice in the study also showed improvements in stress-related behavioral deficits and increased excitatory neurotransmission, providing a potential biological basis for the lasting mood improvements people report after a single psychedelic session.
In clinical depression research, decreased brain modularity (the same network-boundary dissolution seen acutely) predicted improved outcomes six months after treatment, suggesting the temporary disruption may help the brain settle into healthier long-term patterns.
Dose and Timeline
In clinical trials, a standard dose of synthetic psilocybin is 25 milligrams, roughly equivalent to 2.5 grams of dried Psilocybe cubensis mushrooms. A high dose is around 35 milligrams (3.5 grams dried), and doses used in some research go up to 50 to 60 milligrams (5 to 6 grams dried). These conversions assume about 1% psilocybin content per gram of dried mushroom, though potency varies between species and even between individual mushrooms of the same species.
Effects typically begin 20 to 40 minutes after ingestion, peak somewhere around 60 to 90 minutes, and last roughly 4 to 6 hours total. The intensity of the experience scales with dose, but set (your mindset going in) and setting (where you are and who you’re with) heavily influence the subjective character of the experience at any dose level.
Risks to the Brain
Psilocybin is not considered neurotoxic at typical doses, and it carries essentially no risk of physical dependence. The primary acute risk is psychological: a “bad trip” involving intense fear, paranoia, or confusion, which is more likely with higher doses, uncontrolled settings, or pre-existing anxiety. These experiences are distressing but typically resolve as the drug wears off.
A small percentage of psychedelic users develop a condition called hallucinogen persisting perception disorder, or HPPD, where visual disturbances continue long after the drug has left the body. A web-based survey of over 2,400 psychedelic users estimated the prevalence at about 4.2%. The most common symptoms are visual snow (a static-like overlay on vision), trailing images behind moving objects, halos around light sources, and the perception that stationary objects are subtly breathing or moving. Geometric hallucinations, vivid afterimages, and increased sensitivity to patterns and grid-like structures are also frequently reported. HPPD remains poorly understood, and the neuropsychological consequences are still being studied. The condition can be persistent and distressing for those affected, though it appears to be relatively uncommon.
People with a personal or family history of psychotic disorders face a meaningfully higher risk of adverse psychiatric reactions, as psilocybin’s disruption of thalamic filtering and network boundaries can mimic or trigger psychotic symptoms in vulnerable individuals.